Albireo gets FDA, European approval for pediatric liver disease drug
Business Journals,
Albireo Pharma Inc., the rare liver disease-focused biopharma spun out of AstraZeneca in 2008, has its first regulatory…
Albireo Pharma Inc., the rare liver disease-focused biopharma spun out of AstraZeneca in 2008, has its first regulatory…
Albireo Pharma Inc., the rare liver disease-focused biopharma spun out of AstraZeneca in 2008, has its first regulatory…